quinacrine has been researched along with thromboplastin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delvos, U; Janssen, B; Müller-Berghaus, G | 1 |
Almeida Santos, S; Bento, C; Caetano, G; Coucelo, M; Duarte, M; Fidalgo, T; Fortuna, M; Menezes, C; Ribeiro, ML; Sevivas, T | 1 |
2 other study(ies) available for quinacrine and thromboplastin
Article | Year |
---|---|
The inhibitory action of quinacrine on endotoxin-induced tissue factor expression in cultured human endothelial cells is due to cell injury.
Topics: Adenine; Arachidonic Acid; Arachidonic Acids; Blood Coagulation Factors; Cells, Cultured; Endothelium; Endotoxins; Epoprostenol; Humans; L-Lactate Dehydrogenase; Phospholipases A; Quinacrine; Radioimmunoassay; Thromboplastin; Tritium | 1987 |
JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Blood Platelets; Case-Control Studies; CD11b Antigen; Codon; Female; Hemorrhage; Humans; Janus Kinase 2; Male; Middle Aged; Monocytes; Mutation; Neutrophils; Platelet Activation; Platelet Aggregation; Polycythemia Vera; Quinacrine; Thrombocythemia, Essential; Thromboplastin; Thrombosis; Young Adult | 2014 |